Relationship of Familial Hypercholesterolemia and High Low-Density Lipoprotein Cholesterol to Ischemic Stroke: Copenhagen General Population Study

被引:56
作者
Beheshti, Sabina [1 ,2 ,3 ]
Madsen, Christian M. [1 ,2 ,3 ]
Varbo, Anette [1 ,2 ,4 ]
Benn, Marianne [2 ,3 ,4 ]
Nordestgaard, Borge G. [1 ,2 ,3 ,5 ]
机构
[1] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark
[2] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark
[3] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Dept Clin Biochem, Rigshosp, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark
基金
英国医学研究理事会;
关键词
cardiovascular disease; cholesterol; epidemiology; familial hypercholesterolemia; lipids; PERIPHERAL ARTERIAL-DISEASE; LOWERING LDL CHOLESTEROL; CORONARY-HEART-DISEASE; CEREBROVASCULAR-DISEASE; PRIMARY PREVENTION; STATIN THERAPY; LIPID PROFILE; RISK; ASSOCIATION; ATORVASTATIN;
D O I
10.1161/CIRCULATIONAHA.118.033470
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Familial hypercholesterolemia (FH) is a condition with very high concentrations of low-density lipoprotein (LDL) cholesterol and high risk of ischemic heart disease including myocardial infarction. However, there is limited and contradictory information on whether FH and high LDL cholesterol per se confer high risk of ischemic stroke. We tested the hypotheses that individuals in the general population with FH and/or high LDL cholesterol have higher risk of ischemic stroke. Methods: The associations of FH and high LDL cholesterol with ischemic stroke risk were tested in both causal, genetic, and observational analyses using 106412 individuals from the CGPS (Copenhagen General Population Study; 2823 ischemic strokes and 3792 myocardial infarctions) and/or 10 372 individuals from the CCHS (Copenhagen City Heart Study; 945 ischemic strokes and 1142 myocardial infarctions). FH causative mutations were LDLR W23X(rs267607213), W66G(rs121908025) and W556S, and APOB R3500Q(rs5742904). A Mendelian randomization design tested whether high LDL cholesterol per se has a causal effect on ischemic stroke risk, using a combination of the FH causative mutations and common genetic variants associated with high LDL cholesterol. Results: The cumulative incidences in individuals in the CGPS with and without FH causative mutations were similar for ischemic stroke (P=0.50) but not for myocardial infarction (P<0.001): at age 80 years, 4% and 7% of these individuals developed ischemic stroke and 20% and 8% myocardial infarction, with similar results in the CCHS. There was no association between clinical FH and ischemic stroke, except if personal premature ischemic heart disease was included in the clinical FH criteria. Ischemic heart disease at baseline was associated with higher ischemic stroke risk, explaining the higher ischemic stroke risk in those with high LDL cholesterol. For a 1 mmol/L higher LDL cholesterol, the genetic causal risk ratio was 1.11 (0.62-2.02) for ischemic stroke and 1.45 (1.08-1.93) for myocardial infarction. Conclusions: FH and high LDL cholesterol did not confer an increased risk of ischemic stroke. A positive association with ischemic stroke observed for some clinical FH criteria and high LDL cholesterol appears to be due to previous ischemic heart disease, rather than to high LDL cholesterol per se.
引用
收藏
页码:578 / 589
页数:12
相关论文
共 50 条
[1]   Genetic identification of familial hypercholesterolemia within a single US health care system [J].
Abul-Husn, Noura S. ;
Manickam, Kandamurugu ;
Jones, Laney K. ;
Wright, Eric A. ;
Hartzel, Dustin N. ;
Gonzaga-Jauregui, Claudia ;
O'Dushlaine, Colm ;
Leader, Joseph B. ;
Kirchner, H. Lester ;
Lindbuchler, D'Andra M. ;
Barr, Marci L. ;
Giovanni, Monica A. ;
Ritchie, Marylyn D. ;
Overton, John D. ;
Reid, Jeffrey G. ;
Metpally, Raghu P. R. ;
Wardeh, Amr H. ;
Borecki, Ingrid B. ;
Yancopoulos, George D. ;
Baras, Aris ;
Shuldiner, Alan R. ;
Gottesman, Omri ;
Ledbetter, David H. ;
Carey, David J. ;
Dewey, Frederick E. ;
Murray, Michael F. .
SCIENCE, 2016, 354 (6319)
[2]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[3]  
Amarenco P, 2006, NEW ENGL J MED, V355, P549
[4]  
[Anonymous], 1991, BMJ, V303, P893
[5]   2016 ESC/EAS Guidelines for the Management of Dyslipidaemias The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) [J].
Catapano, Alberico L. ;
Graham, Ian ;
De Backer, Guy ;
Wiklund, Olov ;
Chapman, M. John ;
Drexel, Heinz ;
Hoes, Arno W. ;
Jennings, Catriona S. ;
Landmesser, Ulf ;
Pedersen, Terje R. ;
Reiner, Zeljko ;
Riccardi, Gabriele ;
Taskinen, Marja-Riita ;
Tokgozoglu, Lale ;
Verschuren, W. M. Monique ;
Vlachopoulos, Charalambos ;
Wood, David A. ;
Luis Zamorano, Jose .
ATHEROSCLEROSIS, 2016, 253 :281-344
[6]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[7]   Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217 [J].
Benn, Marianne ;
Watts, Gerald F. ;
Tybjaerg-Hansen, Anne ;
Nordestgaard, Borge G. .
EUROPEAN HEART JOURNAL, 2016, 37 (17) :1384-1394
[8]   Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication [J].
Benn, Marianne ;
Watts, Gerald F. ;
Tybjaerg-Hansen, Anne ;
Nordestgaard, Borge G. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11) :3956-3964
[9]   Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus [J].
Besseling, Joost ;
Kastelein, John J. P. ;
Defesche, Joep C. ;
Hutten, Barbara A. ;
Hovingh, G. Kees .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (10) :1029-1036
[10]   Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe [J].
Bots, ML ;
Elwood, PC ;
Nikitin, Y ;
Salonen, JT ;
de Concalves, AF ;
Inzitari, D ;
Sivenius, J ;
Benetou, V ;
Tuomilehto, J ;
Koudstaal, PJ ;
Grobbee, DE .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2002, 56 :I19-I24